Pfizer employs a multi-faceted approach to cancer research, focusing on understanding the biology of cancer and developing innovative therapies. The company invests heavily in clinical trials and collaborates with academic institutions and other pharmaceutical companies to advance its research objectives. Pfizer's commitment to precision medicine aims to tailor treatments based on the genetic makeup of individual tumors.
